Your browser doesn't support javascript.
loading
Technical and safety performance of CT-guided percutaneous microwave ablation for lung tumors: an ablate and resect study.
Blackmon, Shanda H; Sterner, Rosalie M; Eiken, Patrick W; Vogl, Thomas J; Pua, Bradley B; Port, Jeffrey L; Dupuy, Damian E; Callstrom, Matthew R.
Afiliação
  • Blackmon SH; Division of General Thoracic Surgery, Mayo Clinic, Rochester, MN, USA.
  • Sterner RM; Division of General Thoracic Surgery, Mayo Clinic, Rochester, MN, USA.
  • Eiken PW; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Vogl TJ; Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.
  • Pua BB; Division of Interventional Radiology, Department of Radiology, Weill Cornell Medicine, New York, NY, USA.
  • Port JL; Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, USA.
  • Dupuy DE; Department of Diagnostic Imaging, the Warren Alpert Medical School of Brown University, Providence, RI, USA.
  • Callstrom MR; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
J Thorac Dis ; 13(12): 6827-6837, 2021 Dec.
Article em En | MEDLINE | ID: mdl-35070367
ABSTRACT

BACKGROUND:

Percutaneous image-guided thermal ablation has an increasing role in the treatment of primary and metastatic lung tumors. Achieving acceptable clinical outcomes requires better tools for pre-procedure prediction of ablation zone size and shape.

METHODS:

This was a prospective, non-randomized, single-arm, multicenter study conducted by Medtronic (ClinicalTrials.gov ID NCT02323854). Subjects scheduled for resection of metastatic or primary lung nodules underwent preoperative percutaneous microwave ablation. Ablation zones as measured via CT imaging following ablation immediately and before resection surgically versus predicted ablation zones as prescribed by the investigational system software were compared. This CT scan occurred after the ablation was finished but the antenna still in position. Time (minutes) from antenna placement to removal was 23.7±13.1 (n=14); median 21.0 (range, 6.0 to 48.0). The definition of the secondary endpoint of complete ablation was 100% non-viable tumor cells based on nicotinamide adenine dinucleotide hydrogen (NADH) staining. Safety endpoints were type, incidence, and severity of adverse events.

RESULTS:

Fifteen patients (mean age 58.9 years; 67% male; 33% female) were enrolled in the study, 33.3% (5/15) with previous thoracic surgery, 73% (11/15) with metastasis, and 27% (4/15) with primary lung tumors. All underwent percutaneous microwave ablation followed by surgical resection the same day. Complete ablation was detected in 54.4% (6/11), incomplete ablation in 36.4% (4/11), and delayed necrosis in 9.1% (1/11). There were no device-related adverse events. Ablation zone volume was overestimated in all patients.

CONCLUSIONS:

Histological complete ablation was observed in 55% of subjects. CT scanning less than an hour after ablation and tissue shrinkage may account for the smaller zone of ablation observed compared to predicted by the investigational system software.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: J Thorac Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: J Thorac Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
...